Ko, K. J., Jenkins, B., Patel, A., & Lee, K. (2019). A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure. International Neurourology Journal, 23(1), 30. https://doi.org/10.5213/inj.1836176.088
Chicago Style (17th ed.) CitationKo, Kwang Jin, Brenda Jenkins, Anand Patel, and Kyu-Sung Lee. "A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure." International Neurourology Journal 23, no. 1 (2019): 30. https://doi.org/10.5213/inj.1836176.088.
MLA (9th ed.) CitationKo, Kwang Jin, et al. "A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure." International Neurourology Journal, vol. 23, no. 1, 2019, p. 30, https://doi.org/10.5213/inj.1836176.088.